Omeprazol Amarox (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Amarox, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazol Amarox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Amarox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Amarox is a proton pump inhibitor that acts on gastric acid secretion pathways. It is indicated for: - Peptic ulcer disease:  The       ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ s  ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​ - Gastro‑oesophageal reflux disease:  Relieves heartburn and prevents oesophageal damage by maintaining a higher gastric pH. - Zollinger‑Ellison syndrome:  Controls excessive gastric acid secretion associated with gastrin‑producing tumours. - Maintenance therapy for healed erosive oesophagitis:  Reduces recurrence of mucosal injury after healing.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild, transient headache reported in clinical use. - Diarrhoea: loose stools occurring in a minority of patients. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis linked to altered gut flora. - Acute interstitial nephritis: sudden kidney inflammation. - Hypomagnesemia: low serum magnesium levels with prolonged use. - Stevens‑Johnson syndrome: rare severe skin reaction. - Liver enzyme elevation: increased ALT/AST values. - Fracture risk: possible reduction in bone mineral density with long‑term therapy.

When using Omeprazol Amarox, consider the following precautions: - Assess renal function: adjust use in patients with severe kidney impairment. - Evaluate hepatic status: use with caution in moderate to severe liver disease. - Monitor long‑term therapy: periodic assessment of magnesium and bone health is advised. - Pregnancy and lactation: only use if clearly needed after risk‑benefit evaluation. - Drug‑interaction review: check concomitant medications for potential interactions. - Store at ambient temperature: keep below 25°C, in the original packaging, protected from moisture.

Omeprazole may interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir: decreased absorption, compromising HIV therapy. - Dasatinib: lower plasma concentrations, reducing oncologic efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring more frequent monitoring. - Phenytoin: enhanced metabolism leading to reduced seizure control. - Methotrexate: increased serum levels, especially at high doses. - Digoxin: elevated serum concentrations, necessitating dosage adjustment.